Low AMH is not a dead end. At Mother Hospitals, we use individually tailored IVF protocols — including DHEA pre-treatment, micro-stimulation, and quality-first embryology — to give low AMH patients the best possible chance.
Quick Answer: Yes, IVF is possible with low AMH. Low AMH means fewer eggs, not zero eggs. With specialised protocols — DHEA pre-treatment, micro-stimulation, CoQ10 supplementation, and quality-focused embryology — many patients with AMH below 1.0 ng/mL achieve successful pregnancies at Mother Hospitals. The key is acting promptly and choosing the right protocol.
Standard high-dose IVF protocols are not optimal for low AMH patients. Our approach is different — built specifically around maximising the quality of the limited eggs available.
AMH + antral follicle count (AFC) ultrasound + Day 2–3 FSH/LH/E2 + full hormone panel. We don't start planning until we have the complete picture. AFC is often as important as AMH for protocol decisions.
For patients with AMH below 1.0 ng/mL, we recommend a 2–3 month DHEA preparation period (25–75mg/day, doctor prescribed). DHEA increases androgen levels in the follicular environment, supporting egg maturation and response to stimulation. Published data shows improvement in egg numbers and embryo quality.
CoQ10 (300–600mg/day) supports mitochondrial energy production in eggs — critical for quality. Vitamin D and omega-3 DHA are added if deficient. These supplements are started alongside DHEA for maximum effect.
We do not use the same aggressive high-dose FSH approach for all patients. Low AMH patients often respond poorly to high doses and may do better with a gentler protocol. We customise your stimulation based on your AFC, previous response, age, and clinical profile.
With fewer eggs, every egg matters. Our embryology team prioritises optimal culture conditions, extended culture to Day 5 blastocyst where possible, and careful selection of the best embryo for transfer. We do not rush.
For low AMH patients, we decide whether to do a fresh or frozen transfer based on endometrial receptivity and hormone levels on the day of trigger. A receptive endometrium is as important as embryo quality.
For patients with very low AMH who retrieve only 1–2 eggs per cycle, we may recommend embryo banking — freezing embryos from 2–3 sequential stimulation cycles before doing a transfer. This accumulates more embryos and increases cumulative chances.
We believe in honest conversations. Here's what the data says about IVF outcomes based on different AMH levels.
Eggs expected: 3–6 per retrieval
Success rate (under 35): 35–50% per cycle
With DHEA pre-treatment and optimised stimulation, most patients in this range can still have a good IVF experience. Multiple cycles may be needed. Cumulative success over 2–3 cycles can reach 60–75%.
Eggs expected: 2–4 per retrieval
Success rate (under 35): 25–40% per cycle
Careful stimulation, quality-focused embryology, and possibly embryo banking. Success is possible, but expectations must be realistic. Multiple cycle planning is usually advised from the outset.
Eggs expected: 0–2 per retrieval
Success rate: Variable; 10–25% possible with good eggs
Even 1 good blastocyst can lead to a healthy pregnancy. We attempt stimulation before advising against own-egg IVF. Options including donor eggs are discussed honestly if cycles yield no usable embryos.
Best combination for success
Young age preserves egg quality even when quantity is low. A 30-year-old with AMH 0.4 ng/mL has much better prospects than a 41-year-old with AMH 0.4 ng/mL. Age is the strongest quality indicator. If you are under 35 with low AMH — there is real reason for optimism.
Many of our most gratifying outcomes involve patients who came to us after being told elsewhere that IVF was "not worth trying." With the right protocol, the right mindset, and the right timing — outcomes exceed expectations.
Discuss Your Case with UsThe most evidence-backed supplement for low AMH IVF preparation. DHEA is an androgen precursor that increases intra-follicular androgen levels, improving the follicular environment for egg development. Typically prescribed at 25–75mg/day for 8–12 weeks before IVF. Must be prescribed — do not self-administer.
Supports mitochondrial energy production in eggs. Eggs are metabolically demanding cells — CoQ10 provides the energy substrate for maturation and fertilisation. Recommended at 300–600mg/day for at least 8 weeks before IVF. Ubiquinol form may have better absorption.
Docosahexaenoic acid (DHA) supports egg membrane fluidity and embryo development. Found in fatty fish or as a supplement. Typical dose: 1,000mg DHA/day. Also benefits endometrial receptivity and fetal brain development after conception.
Vitamin D deficiency is very common in India and is associated with reduced IVF success rates. Testing your Vitamin D level and correcting deficiency before IVF is recommended. Target level: 40–60 ng/mL (100–150 nmol/L).
Plus folic acid (400–800mcg/day), and any other supplements prescribed based on your blood results. Dr. Prashanthi Reddy will provide a complete pre-IVF supplement plan at your consultation.